Alexander finn Site

Need help? Text us, and a team member will reply in mins +1 123 456 7891

Have questions about bpc-157?
Text us: +1 123456789

Tirzepatide

Nootropic Compound

$39.00

Quantity

Research Use Only

These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.

What is Tirzepatide?

 Tirzepatide, also referred to as Tirzepatide, is a synthetic peptide designed to mimic GLP-1 and GIP signaling pathways, two incretin-related systems studied for their roles in receptor activation, cellular communication, and peptide stability in controlled laboratory environments.

Made in the USA

Quality controlled from start to finish.
No outsourcing.

Need Help?

Send us a message.

Tirzepatide Overview
Tirzepatide, commonly known as Tirzepatide, is a synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This combined receptor activity is being examined in laboratory and clinical research models for its potential involvement in metabolic pathway regulation, insulin signaling, and energy balance. Current studies focus on how it influences cellular communication and systemic hormone signaling.

History
The development of Tirzepatide, or Tirzepatide, originates from incretin-related research focused on metabolic regulation. Early discoveries identified GLP-1 and GIP as key hormones involved in glucose balance and endocrine signaling. Following the success of GLP-1 receptor agonists in research models, scientists explored dual receptor strategies. Tirzepatide was synthesized during the 2010s as an investigational peptide designed to activate both GIP and GLP-1 receptors, allowing researchers to study combined signaling effects within metabolic and endocrine research systems.

Tirzepatide Structure

CAS #: 2023788-19-2

Molecular Formula: C₂₂₅H₃₆₀N₆₂O₈₅

Molecular Weight: 4813.5 g/mol

PubChem ID: 137346133

Research Findings
Tirz, also referred to as Tirzepatide, has been examined in structural, metabolic, and molecular research models, with studies exploring its influence on insulin secretion, glucose regulation, and hormone signaling pathways. Findings also highlight its involvement in receptor activity, intracellular communication, and coordinated hormone interactions within preclinical laboratory environments.

Key Areas of Research:

  • Pathway Interaction: Activity within GIP and GLP-1 signaling pathways
  • Metabolic: Energy regulation, glucose metabolism, signaling balance
  • Cellular: GIP and GLP-1 receptor activity, cellular response mechanisms
  • Molecular: Pathway crosstalk, intracellular signaling, hormone biology

Together, these observations indicate broad experimental relevance for Tirzepatide across structural, metabolic, and molecular research systems. By influencing insulin-related pathways and interacting with multiple hormone receptors, Tirzepatide provides a useful framework for studying glucose regulation, metabolic balance, and integrated hormonal signaling within controlled laboratory models.

Description

Tirzepatide Overview
Tirzepatide, commonly known as Tirzepatide, is a synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This combined receptor activity is being examined in laboratory and clinical research models for its potential involvement in metabolic pathway regulation, insulin signaling, and energy balance. Current studies focus on how it influences cellular communication and systemic hormone signaling.

History
The development of Tirzepatide, or Tirzepatide, originates from incretin-related research focused on metabolic regulation. Early discoveries identified GLP-1 and GIP as key hormones involved in glucose balance and endocrine signaling. Following the success of GLP-1 receptor agonists in research models, scientists explored dual receptor strategies. Tirzepatide was synthesized during the 2010s as an investigational peptide designed to activate both GIP and GLP-1 receptors, allowing researchers to study combined signaling effects within metabolic and endocrine research systems.

Tirzepatide Structure

CAS #: 2023788-19-2

Molecular Formula: C₂₂₅H₃₆₀N₆₂O₈₅

Molecular Weight: 4813.5 g/mol

PubChem ID: 137346133

Research Findings
Tirz, also referred to as Tirzepatide, has been examined in structural, metabolic, and molecular research models, with studies exploring its influence on insulin secretion, glucose regulation, and hormone signaling pathways. Findings also highlight its involvement in receptor activity, intracellular communication, and coordinated hormone interactions within preclinical laboratory environments.

Key Areas of Research:

  • Pathway Interaction: Activity within GIP and GLP-1 signaling pathways
  • Metabolic: Energy regulation, glucose metabolism, signaling balance
  • Cellular: GIP and GLP-1 receptor activity, cellular response mechanisms
  • Molecular: Pathway crosstalk, intracellular signaling, hormone biology

Together, these observations indicate broad experimental relevance for Tirzepatide across structural, metabolic, and molecular research systems. By influencing insulin-related pathways and interacting with multiple hormone receptors, Tirzepatide provides a useful framework for studying glucose regulation, metabolic balance, and integrated hormonal signaling within controlled laboratory models.

Additional information

Pcs

Pack of 10, Single Vial

Strength

10mg

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide”

Your email address will not be published. Required fields are marked *

Text us, our dedicated team is here to help.

Reach out and get a response within minutes

+1 123456789